FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1485275344> ?p ?o ?g. }

• W1485275344 endingPage "137" @default.
• W1485275344 startingPage "131" @default.
• W1485275344 abstract "Background and Aims: Insulin resistance appears to be a major factor involved in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). In this pilot study, we examined the effect of pioglitazone, an insulin-sensitizing agent, on patients with NAFLD and NASH. Methods: The medical records of patients referred to our clinic over a 48-month period were reviewed, and individuals with a clinical diagnosis of NAFLD or NASH, who were overweight (BMI|“|with chronic elevated liver enzymes were included in this study. The patients were either treated with pioglitazone or advised to start a weight-reduction diet and exercise, in a non-blinded random method based on the treating physicians' discretion. Results: Thirty-four patients' charts were retrospectively analyzed. Nineteen patients were treated with pioglitazone and 15 patients were advised to start a weight reduction diet and exercise. There were significant improvements in mean ALT and AST in the pioglitazone group at the end of treatment when compared to pretreatment values and to the diet/exercise group. There were no significant changes in the lipid profiles, body mass index or fasting glucose levels between baseline and at the end of the therapy in either group. There were no adverse side effects, including hypoglycemia, in patients treated with pioglitazone. Conclusions: Preliminary results using pioglitazone in patients with NAFLD or NASH are promising. However, larger prospective studies are further needed to validate the results of our study and to examine histological response." @default.
• W1485275344 created "2016-06-24" @default.
• W1485275344 creator A5028784180 @default.
• W1485275344 creator A5036613802 @default.
• W1485275344 creator A5053565165 @default.
• W1485275344 date "2007-01-01" @default.
• W1485275344 modified "2023-10-18" @default.
• W1485275344 title "A Pilot Study of Pioglitazone for the Treatment of Non-Alcoholic Fatty Liver Disease" @default.
• W1485275344 cites W148405191 @default.
• W1485275344 cites W1530129189 @default.
• W1485275344 cites W1976560133 @default.
• W1485275344 cites W1982578021 @default.
• W1485275344 cites W1983417944 @default.
• W1485275344 cites W1996641308 @default.
• W1485275344 cites W1999571240 @default.
• W1485275344 cites W2002502142 @default.
• W1485275344 cites W2006591225 @default.
• W1485275344 cites W2016199234 @default.
• W1485275344 cites W2020505711 @default.
• W1485275344 cites W2028220296 @default.
• W1485275344 cites W2029811522 @default.
• W1485275344 cites W2040538211 @default.
• W1485275344 cites W2047173601 @default.
• W1485275344 cites W2054363438 @default.
• W1485275344 cites W2061752687 @default.
• W1485275344 cites W2061950292 @default.
• W1485275344 cites W2062663604 @default.
• W1485275344 cites W2065788317 @default.
• W1485275344 cites W2068924443 @default.
• W1485275344 cites W2070213099 @default.
• W1485275344 cites W2080858771 @default.
• W1485275344 cites W2082185635 @default.
• W1485275344 cites W2084310268 @default.
• W1485275344 cites W2086482588 @default.
• W1485275344 cites W2087011218 @default.
• W1485275344 cites W2087829753 @default.
• W1485275344 cites W2092268077 @default.
• W1485275344 cites W2125624346 @default.
• W1485275344 cites W2128925357 @default.
• W1485275344 cites W2141158324 @default.
• W1485275344 cites W2162051951 @default.
• W1485275344 cites W2253667517 @default.
• W1485275344 hasPublicationYear "2007" @default.
• W1485275344 type Work @default.
• W1485275344 sameAs 1485275344 @default.
• W1485275344 citedByCount "1" @default.
• W1485275344 crossrefType "journal-article" @default.
• W1485275344 hasAuthorship W1485275344A5028784180 @default.
• W1485275344 hasAuthorship W1485275344A5036613802 @default.
• W1485275344 hasAuthorship W1485275344A5053565165 @default.
• W1485275344 hasConcept C126322002 @default.
• W1485275344 hasConcept C134018914 @default.
• W1485275344 hasConcept C2776954865 @default.
• W1485275344 hasConcept C2777180221 @default.
• W1485275344 hasConcept C2777391703 @default.
• W1485275344 hasConcept C2778384471 @default.
• W1485275344 hasConcept C2778772119 @default.
• W1485275344 hasConcept C2779134260 @default.
• W1485275344 hasConcept C2779478299 @default.
• W1485275344 hasConcept C2780221984 @default.
• W1485275344 hasConcept C2780586474 @default.
• W1485275344 hasConcept C511355011 @default.
• W1485275344 hasConcept C555293320 @default.
• W1485275344 hasConcept C71924100 @default.
• W1485275344 hasConcept C90924648 @default.
• W1485275344 hasConceptScore W1485275344C126322002 @default.
• W1485275344 hasConceptScore W1485275344C134018914 @default.
• W1485275344 hasConceptScore W1485275344C2776954865 @default.
• W1485275344 hasConceptScore W1485275344C2777180221 @default.
• W1485275344 hasConceptScore W1485275344C2777391703 @default.
• W1485275344 hasConceptScore W1485275344C2778384471 @default.
• W1485275344 hasConceptScore W1485275344C2778772119 @default.
• W1485275344 hasConceptScore W1485275344C2779134260 @default.
• W1485275344 hasConceptScore W1485275344C2779478299 @default.
• W1485275344 hasConceptScore W1485275344C2780221984 @default.
• W1485275344 hasConceptScore W1485275344C2780586474 @default.
• W1485275344 hasConceptScore W1485275344C511355011 @default.
• W1485275344 hasConceptScore W1485275344C555293320 @default.
• W1485275344 hasConceptScore W1485275344C71924100 @default.
• W1485275344 hasConceptScore W1485275344C90924648 @default.
• W1485275344 hasIssue "3" @default.
• W1485275344 hasOpenAccess W1485275344 @default.
• W1485275344 hasRelatedWork W1700352558 @default.
• W1485275344 hasRelatedWork W1902670387 @default.
• W1485275344 hasRelatedWork W1966811669 @default.
• W1485275344 hasRelatedWork W2028485145 @default.
• W1485275344 hasRelatedWork W2110559431 @default.
• W1485275344 hasRelatedWork W2131820215 @default.
• W1485275344 hasRelatedWork W2334983296 @default.
• W1485275344 hasRelatedWork W2383628834 @default.
• W1485275344 hasRelatedWork W2416783687 @default.
• W1485275344 hasRelatedWork W2470709274 @default.
• W1485275344 hasRelatedWork W2565809852 @default.
• W1485275344 hasRelatedWork W2604619917 @default.
• W1485275344 hasRelatedWork W2964628172 @default.
• W1485275344 hasRelatedWork W2994786801 @default.
• W1485275344 hasRelatedWork W3043941548 @default.
• W1485275344 hasRelatedWork W3120762992 @default.

• next